DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1DR. REDDY'S LABORATORIES LIMITED Hyderabad IN
01 1Glimepiride
01 1India
01 1Valid
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Certificate Number : R1-CEP 2008-072 - Rev 05
Status : Valid
Issue Date : 2022-03-08
Type : Chemical
Substance Number : 2223
20
Dr. Reddy's Laboratories Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their significant offerings is Glimepiride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2008-072 - Rev 05
This Chemical Type CEP, issued on March 08, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2223 associated with this CEP further emphasizes
LOOKING FOR A SUPPLIER?